EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Saudi Heart Association Position Statement on NT-proBNP for Cardiovascular Risk Screening in Asymptomatic Adults with Type 2 Diabetes Mellitus

Waleed AlHabeeb, Adel Tash, Abdullah M Abdullah Arabe, Lamya AlZubaidi, Ayman Al Hayek, Mohammed R Al Safi, Malak A Almashali

Journal of the Saudi Heart Association · 22.12.2025 · 37 (4)

DOI: 10.37616/2212-5043.1466 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the Saudi Heart Association, online erschienen am 22.12.2025. Verfasst von Waleed AlHabeeb und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiac Sciences, King Saud University, Riyadh, Saudi Arabia. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Type 2 diabetes mellitus (DM) is a chronic disease with a rapidly increasing prevalence, posing a significant public health challenge worldwide and in Saudi Arabia. Cardiovascular disease (CVD) is the leading cause of death among patients with T2DM, necessitating early detection and intervention to prevent disease progression. Elevated natriuretic peptide levels, particularly N-terminal pro–B-type natriuretic peptide (NT-proBNP), are promising biomarkers for CVD risk stratification in individuals with T2DM. However, the integration of these biomarkers in clinical management remains limited.

Methods

Published evidence and existing guidelines/consensuses related to the use of NT-proBNP for CVD risk stratification in T2DM patients were reviewed and discussed by a multidisciplinary expert panel from Saudi Arabia. The panel also considered the unique characteristics of the local Saudi population, healthcare system, resources, and medical expertise. Results and conclusions: NT-proBNP-based screening holds significant promise for improving CVD outcomes in T2DM patients by identifying at-risk individuals and guiding management approaches. Based on available evidence, the Saudi Heart Association (SHA) developed an evidence-based position statement on the use of NT-proBNP for CVD risk stratification in patients with T2DM who have no established CVD (asymptomatic). The proposed algorithm for NT-proBNP-based screening aims to improve the early identification of at-risk patients with T2DM, inform clinical management decisions, and enhance patient outcomes in Saudi Arabia. The algorithm includes age-adapted thresholds to reduce unnecessary referrals and medical testing. The SHA recognizes the need for further research and local data collection on NT-proBNP-based screening, in addition to clinician training to address the limitations and improve the practical implementation of NT-proBNP screening in routine clinical practice.

Schlagwörter

Stichwörter der Autor:innen

Cardiovascular diseaseNTproBNPRisk stratificationSaudi ArabiaScreeningType 2 diabetes mellitus

Autor:innen und Institutionen

  • Department of Cardiac Sciences, King Saud University, Riyadh, Saudi Arabia.
  • Saudi Health Council, National Heart Center, Riyadh, Saudi Arabia.
  • Diabetes Centers and Diabetic Foot Centers, Ministry of Health, Riyadh, Saudi Arabia.
  • Clinical Audit Health Adaa, Health Center, Ministry of Health, Riyadh, Saudi Arabia.
  • Department of Endocrinology and Diabetes, Health Education Administration, Prince Sultan Military Medical City, Riyadh, Saudi Arabia.
  • Medical Laboratory-POCT, King Fahad Armed Forces Hospital, Jeddah, Saudi Arabia.

Zitieren

APA

AlHabeeb, W., Tash, A., Abdullah Arabe, A. M., AlZubaidi, L., Al Hayek, A., Al Safi, M. R., & Almashali, M. A. (2025). Saudi Heart Association Position Statement on NT-proBNP for Cardiovascular Risk Screening in Asymptomatic Adults with Type 2 Diabetes Mellitus. Journal of the Saudi Heart Association, 37(4). https://doi.org/10.37616/2212-5043.1466

Vancouver

AlHabeeb W, Tash A, Abdullah Arabe AM, AlZubaidi L, Al Hayek A, Al Safi MR, et al. Saudi Heart Association Position Statement on NT-proBNP for Cardiovascular Risk Screening in Asymptomatic Adults with Type 2 Diabetes Mellitus. Journal of the Saudi Heart Association. 2025;37(4). doi:10.37616/2212-5043.1466

BibTeX
@article{AlHabeeb2025,
  author = {AlHabeeb, Waleed and Tash, Adel and Abdullah Arabe, Abdullah M and AlZubaidi, Lamya and Al Hayek, Ayman and Al Safi, Mohammed R and Almashali, Malak A},
  title = {Saudi Heart Association Position Statement on NT-proBNP for Cardiovascular Risk Screening in Asymptomatic Adults with Type 2 Diabetes Mellitus},
  journal = {Journal of the Saudi Heart Association},
  year = {2025},
  volume = {37},
  number = {4},
  doi = {10.37616/2212-5043.1466}
}
Kostenlos starten →